Heart Disease News and Research

Latest Heart Disease News and Research

Genetic basis unknown in many children with mental retardation and developmental delays

Researchers from four laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities recently identified a previously unrecognized genetic disorder.

10 Mar 2010

Early administration of metformin can prevent long-term complications of diabetes: Study

The sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association.

10 Mar 2010

2010 Max Planck Research Award for Dr. Timothy Bromage from NYU College of Dentistry

New York University College of Dentistry's Dr. Timothy Bromage has been selected to receive the 2010 Max Planck Research Award. Dr. Bromage will collaborate with Dr. Friedemann Schrenk of Frankfurt's Senckenberg Research Institute to research the microanatomical structure of bones and teeth, and the links between metabolic states, growth rates, life spans, and biological features such as sex and body size.

10 Mar 2010

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

People with MS (Multiple Sclerosis) and others suffering with a range of often debilitating inflammatory conditions such as Chronic Fatigue Syndrome and Fibromyalgia, will take heart from advances in treatment for their conditions, and will follow events at The 2nd European LDN Conference with interest.

10 Mar 2010

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the “Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus” trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.

10 Mar 2010

Lowering levels of Coonexin46 with use of siRNA will help prevent tumor formation

What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma.

10 Mar 2010

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company’s novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

10 Mar 2010

Researchers to collaborate on the largest clinical trial of hypothermia for stroke

Researchers at Cedars-Sinai Medical Center in Los Angeles, the University of California, San Diego School of Medicine, and UTHealth's Medical School will collaborate on the largest clinical trial of hypothermia (brain cooling) for stroke to date.

10 Mar 2010

Bilateral oophorectomy may do more harm than good

Removal of the ovaries (bilateral oophorectomy) while performing a hysterectomy is common practice to prevent the subsequent development of ovarian cancer. This prophylactic procedure is performed in 55% of all U.S. women having a hysterectomy, or approximately 300,000 times each year. An article in the March/April issue of The Journal of Minimally Invasive Gynecology suggests that this procedure may do more harm than good.

10 Mar 2010

Winners of NMSIS scholarship award

Two winners have been selected for the Promising New Investigators Travel Scholarship Awards given annually by the Neuroleptic Malignant Syndrome Information Service (NMSIS).

10 Mar 2010

OVA1 blood test aids in pre-surgical evaluation of women for ovarian cancer now available through Quest Diagnostics

OVA1™, the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc., the world's leading cancer diagnostics provider.

From Quest Diagnostics 10 Mar 2010

WebMD Health Exchange platform launched to help consumers get health and wellness support

WebMD Health Corp., the leading source of health information, today announced the launch of WebMD Health Exchange, a new health social networking platform that provides a unique way for consumers to get health and wellness support from the world's largest community of online health-informed consumers.

10 Mar 2010

Racial disparities persist in hospice use

Even as medical caregivers try to change practices, racial disparities in hospice care continue, according to a study in the March 8 issue of the Archives of Internal Medicine.

10 Mar 2010

GeNO's Nitrosyl Delivery Platform IND receives FDA clearance

GeNO LLC a privately held, advanced development-stage technology company, today announced that the U.S. Food and Drug Administration has granted clearance of its Investigational New Drug application for its stand-alone gas cylinder Nitrosyl™ Delivery Platform.

10 Mar 2010

Obese patients with colon cancer are at greater risk for death

Obese patients with colon cancer are at greater risk for death or recurrent disease compared to those who are within a normal weight range, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.

10 Mar 2010

Governor Kaine urges Hispanics to take part in the final push for health reform

Following President Obama's call on Congress last week to act now to pass health insurance reform, DNC Chairman Tim Kaine issued this Spanish-language video calling on Latinos to take part in the final push for health reform – reform that would benefit the Latino community.

10 Mar 2010

Scivanta Medical announces initial clinical trial results for SCMS

Scivanta Medical Corporation, today announced that the results of its initial clinical trial for the Scivanta Cardiac Monitoring System (SCMS) clearly indicate that the SCMS can accurately measure cardiac performance as expected by the company. This clinical trial was performed at Kaleida Health/Millard Fillmore Hospital in Buffalo, New York.

10 Mar 2010

Study shows strawberries can provide immense health benefits

When it comes to eating healthy, most people know it's a good long-term choice, but what they may not know is that eating certain foods daily can provide immediate health benefits.

10 Mar 2010

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

9 Mar 2010

Aton Pharma introduces authorized generic version of Timoptic-XE

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE® (timolol maleate ophthalmic gel forming solution). Timoptic-XE is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Aton also announced that it will continue to make available branded Timoptic-XE.

9 Mar 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Genetic basis unknown in many children with mental retardation and developmental delays

Early administration of metformin can prevent long-term complications of diabetes: Study

2010 Max Planck Research Award for Dr. Timothy Bromage from NYU College of Dentistry

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Lowering levels of Coonexin46 with use of siRNA will help prevent tumor formation

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Researchers to collaborate on the largest clinical trial of hypothermia for stroke

Bilateral oophorectomy may do more harm than good

Winners of NMSIS scholarship award

OVA1 blood test aids in pre-surgical evaluation of women for ovarian cancer now available through Quest Diagnostics

WebMD Health Exchange platform launched to help consumers get health and wellness support

Racial disparities persist in hospice use

GeNO's Nitrosyl Delivery Platform IND receives FDA clearance

Obese patients with colon cancer are at greater risk for death

Governor Kaine urges Hispanics to take part in the final push for health reform

Scivanta Medical announces initial clinical trial results for SCMS

Study shows strawberries can provide immense health benefits

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

Aton Pharma introduces authorized generic version of Timoptic-XE

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in